Abstract:Protein arginine methyltransferase 1 (PRMT1) and co‐activator‐associated arginine methyltransferase 1 (CARM1) are critical components of a diverse set of intracellular functions including cell signaling and transcriptional regulation. Despite the limited number of studies investigating PRMT biology in muscle, evidence strongly suggests that PRMT1 and CARM1 are important players in the regulation of skeletal muscle plasticity. However, their role in disuse‐induced muscle remodeling is unknown. Thus, our study objective was to determine whether denervation‐induced muscle disuse alters PRMT expression and activity in skeletal muscle and to contextualize PRMT biology within the early disuse‐evoked signaling events that precede muscle atrophy. After unilateral sectioning of the sciatic nerve, mice were subjected to 6 (n = 7), 12 (n = 7), 24 (n = 6), 72 (n = 5), or 168 (n = 4) hours of denervation. The contralateral limb served as an internal control. Western blot analyses were employed to determine protein expression levels in the denervated tibialis anterior (TA) muscle, relative to the contralateral, non‐denervated, control TA muscle across the experimental time course. A ~25% reduction (p < 0.05) in TA muscle mass was observed in the denervated hind limb after 168 hours. PRMT1 and CARM1 protein expression were significantly increased by 3‐ and 1.3‐fold, respectively, in the denervated hind limb, as compared to the control limb after 72 and 168 hours of inactivity. This differential response to denervation‐induced muscle disuse suggests a unique sensitivity to, or regulation by, potential upstream signaling and transcriptional pathways. These denervation‐induced increases in PRMT expression were accompanied by a ~15–25% elevation in cellular mono‐methyl arginine content at 72 and 168 hours, a marker of global PRMT methyltransferase activity. Muscle RING‐finger protein‐1 (MuRF1) protein expression was also significantly elevated 2.5–3‐fold after 72 and 168 hours of denervation, suggesting that PRMT expression may be mediated by factors governing the muscle atrophy program. Peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α) protein expression was diminished by ~40% (p < 0.05) in the denervated limb after 6 hours and remained depressed throughout the time course. In contrast, p38 mitogen‐activated protein kinase (MAPK) phosphorylation status (phosphorylated/total) tended to be elevated by ~10–50% in the denervated muscle throughout the experimental time course. AMP‐activated protein kinase (AMPK) phosphorylation status was lowered by ~40% (p < 0.05) after 6 and 12 hours of denervation. By 168 hours, AMPK phosphorylation status was 50% greater in the denervated limb than in the control limb. Our data suggest that alterations in AMPK, p38 MAPK, and PGC‐1α signaling are among the earliest signals that precede the induction of the atrophy program in response to neurogenic muscle disuse. Furthermore, PRMT1 and CARM1 may contribute to the remodeling of muscle during denervation‐induced atrophy. Support or Funding Information Natural Sciences and Engineering Research Council of Canada and Canada Research Chairs

Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase

Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength

Utilization of the Rat Tibial Nerve Transection Model to Evaluate Cellular and Molecular Mechanisms Underpinning Denervation-Mediated Muscle Injury

Persistent muscle fiber regeneration in long term denervation. Past, present, future

Dietary Genistein Prevents Denervation-Induced Muscle Atrophy in Male Rodents via Effects on Estrogen Receptor-α.

GDF5 as a rejuvenating treatment for age-related neuromuscular failure

Inhibition of the Prostaglandin-Degrading Enzyme 15-Pgdh Potentiates Tissue Regeneration

GW8510 Alleviated Muscle Atrophy and Skeletal Muscle Dysfunction in Mice Through AMPK/PGC1α Signaling

G9a Promotes Muscular Atrophy in Chronic Aging and Acute Denervation

Angiotensin 1‐7 reduces muscle atrophy and function loss following 16 week denervation

Muscle Injuries Induce a Prostacyclin‐PPARγ/PGC1a‐FAO Spike That Boosts Regeneration

GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury

Protein Arginine Methyltransferase Expression During An Acute Time Course Of Denervation‐Induced Skeletal Muscle Plasticity

Human Muscle Progenitor Cells Overexpressing Neurotrophic Factors Improve Neuronal Regeneration in a Sciatic Nerve Injury Mouse Model

Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1α and Integrating Mitochondrial Electron Transport Chain Complexes

Glial cell line-derived neurotrophic factor (GDNF) attenuates the peripheral neuromuscular dysfunction without inhibiting the activation of spinal microglia/monocyte

Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice

Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse

Heat shock protein is a key therapeutic target for nerve repair in autoimmune peripheral neuropathy and severe peripheral nerve injury

Skeletal muscle reprogramming enhances reinnervation after peripheral nerve injury

Remodeling of neuromuscular junctions in target muscle following nerve regeneration in mice after delayed peripheral nerve repair